1. Luger, T. A., B. M. Stadler, B. M. Luger, B. J. Mathieson, M. Mage, J. A. Schmidt, andJ. J. Oppenheim. 1981. Murine epidermal cell-derived thymocyte-activating factor resembles murine interleukin-1.J. Immunol. 128:2147?2152.
2. Powanda, M. C., andW. R. Beisel. 1982. Hypothesis: Leukocyte endogenous mediator/ endogenous pyrogen/lymphocyte activating factor modulates the development of nonspecific and specific immunity.Am. J. Clin. Nutr. 35:762?768.
3. Gery, I. 1984. Interleukin-1: Uniqueness of its production and spectrum of activities.Lymphokines 9:109?125.
4. Sipe, J. D., S. D. Vogel, M. B. Sztein, M. Skinner, andA. S. Cohen. 1982. The role of interleukin-1 in acute phase serum amyloid A (SAA) and serum amyloid P (SAP) biosynthesis.In C-Reactive Protein and the Plasma Protein Response to Tissue Injury. I. Kushner, J. E. Volanakis, and H. Gewurz, editors. New York Academy of Sciences, New York. 137?148.
5. Gahring, L. C., M. Baltz, andM. B. Pepys. 1984. The effect of ultraviolet radiation on the production of ETAF/IL-1 in vivo and in vitro.Proc. Natl. Acad. Sci. U.S.A. 81:1198?1202.